1. Home
  2. MARA vs STVN Comparison

MARA vs STVN Comparison

Compare MARA & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Digital Holdings Inc.

MARA

Marathon Digital Holdings Inc.

HOLD

Current Price

$8.01

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$13.41

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MARA
STVN
Founded
2010
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
EDP Services
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.0B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
MARA
STVN
Price
$8.01
$13.41
Analyst Decision
Buy
Buy
Analyst Count
12
3
Target Price
$17.95
$25.67
AVG Volume (30 Days)
44.4M
461.8K
Earning Date
05-07-2026
03-04-2026
Dividend Yield
N/A
0.46%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$907,093,000.00
N/A
Revenue This Year
N/A
$9.67
Revenue Next Year
$13.31
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
38.20
N/A
52 Week Low
$6.66
$13.58
52 Week High
$23.45
$28.00

Technical Indicators

Market Signals
Indicator
MARA
STVN
Relative Strength Index (RSI) 42.90 33.35
Support Level $7.89 N/A
Resistance Level $10.03 $16.69
Average True Range (ATR) 0.67 0.65
MACD -0.07 -0.11
Stochastic Oscillator 10.75 19.45

Price Performance

Historical Comparison
MARA
STVN

About MARA Marathon Digital Holdings Inc.

MARA Holdings Inc leverages digital asset computing to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value. The company also offers technology solutions to optimize data center operations, including next-generation liquid immersion cooling and firmware for Bitcoin miners. It is focused on computing for, acquiring, and holding digital assets as a long-term investment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: